Logo image of KIDS

ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis

NASDAQ:KIDS - US68752L1008 - Common Stock

20.2 USD
+1.05 (+5.48%)
Last: 8/22/2025, 8:20:03 PM
20.2 USD
0 (0%)
After Hours: 8/22/2025, 8:20:03 PM
Fundamental Rating

3

Taking everything into account, KIDS scores 3 out of 10 in our fundamental rating. KIDS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of KIDS is average, but there are quite some concerns on its profitability. KIDS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year KIDS has reported negative net income.
In the past year KIDS has reported a negative cash flow from operations.
In the past 5 years KIDS reported 4 times negative net income.
In the past 5 years KIDS always reported negative operating cash flow.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

With a decent Return On Assets value of -8.29%, KIDS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Looking at the Return On Equity, with a value of -11.75%, KIDS is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
ROA -8.29%
ROE -11.75%
ROIC N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

The Gross Margin of KIDS (71.54%) is better than 82.35% of its industry peers.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
KIDS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for KIDS has been increased compared to 5 years ago.
Compared to 1 year ago, KIDS has a worse debt to assets ratio.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.09 indicates that KIDS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.09, KIDS is in the better half of the industry, outperforming 63.10% of the companies in the same industry.
KIDS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.27, KIDS perfoms like the industry average, outperforming 49.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.09
ROIC/WACCN/A
WACC8.62%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

KIDS has a Current Ratio of 6.66. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS has a better Current ratio (6.66) than 84.49% of its industry peers.
KIDS has a Quick Ratio of 3.43. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.43, KIDS is doing good in the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 3.43
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

KIDS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.92%.
The Revenue has grown by 26.08% in the past year. This is a very strong growth!
Measured over the past years, KIDS shows a very strong growth in Revenue. The Revenue has been growing by 23.04% on average per year.
EPS 1Y (TTM)-63.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)26.08%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%15.68%

3.2 Future

KIDS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.84% yearly.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.39% yearly.
EPS Next Y17.4%
EPS Next 2Y12.4%
EPS Next 3Y12.84%
EPS Next 5YN/A
Revenue Next Year17.88%
Revenue Next 2Y17.51%
Revenue Next 3Y17.39%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KIDS. In the last year negative earnings were reported.
Also next year KIDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

KIDS's earnings are expected to grow with 12.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.4%
EPS Next 3Y12.84%

More info and screens

0

5. Dividend

5.1 Amount

KIDS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (8/22/2025, 8:20:03 PM)

After market: 20.2 0 (0%)

20.2

+1.05 (+5.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners72%
Inst Owner Change0.49%
Ins Owners5.23%
Ins Owner Change4.01%
Market Cap506.41M
Analysts83.08
Price Target34.53 (70.94%)
Short Float %7.02%
Short Ratio7.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.4%
Min EPS beat(2)-0.09%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-37.85%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)4
Avg EPS beat(8)-14.53%
EPS beat(12)7
Avg EPS beat(12)-2.09%
EPS beat(16)10
Avg EPS beat(16)12.68%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.5%
Revenue beat(12)3
Avg Revenue beat(12)-0.99%
Revenue beat(16)4
Avg Revenue beat(16)-1.21%
PT rev (1m)-7.06%
PT rev (3m)-9.89%
EPS NQ rev (1m)-10.36%
EPS NQ rev (3m)-35.5%
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-4.52%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-1.49%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.29
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 2.87
EV/EBITDA N/A
EPS(TTM)-1.79
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-1.53
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS8.8
BVpS14.18
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.29%
ROE -11.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.54%
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.17%
Cap/Sales 4.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 3.43
Altman-Z 2.09
F-Score3
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y17.4%
EPS Next 2Y12.4%
EPS Next 3Y12.84%
EPS Next 5YN/A
Revenue 1Y (TTM)26.08%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%15.68%
Revenue Next Year17.88%
Revenue Next 2Y17.51%
Revenue Next 3Y17.39%
Revenue Next 5YN/A
EBIT growth 1Y-21.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.75%
EBIT Next 3Y50.36%
EBIT Next 5YN/A
FCF growth 1Y-22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.7%
OCF growth 3YN/A
OCF growth 5YN/A